Zogenix and Astellas have made available Sumavel DosePro (sumatriptan injection), a selective 5-HT1B/1D receptor agonist in a needle-free delivery system, for the acute treatment of migraine attacks, with or without aura, and the acute treatment of cluster headache episodes. Sumavel DosePro first received FDA approval in July 2009.

Sumavel DosePro is available as a 6mg/0.5mL single-use, disposable injection.

For more information call (866) ZOGENIX or visit www.zogenix.com.